Human Genome Sciences Stock Price, News & Analysis (NASDAQ:HGSI)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Human Genome Sciences (NASDAQ:HGSI)

Human Genome Sciences logoHuman Genome Sciences, Inc. (HGS) is a biopharmaceutical company. The Company's products include BENLYSTA (belimumab) for systemic lupus erythematosus (SLE) and raxibacumab for inhalation anthrax. HGS continues to deliver raxibacumab to the United States Strategic National Stockpile (SNS) for emergency use in treating inhalation anthrax. In addition to the Company's internal pipeline, it has financial rights to two drugs that GlaxoSmithKline (GSK) has advanced to late-stage development. These include darapladib and albiglutide. A randomized Phase 2 trial is evaluating mapatumumab in combination with Nexavar (sorafenib) for the treatment of advanced hepatocellular cancer. The Company manufactures multiple protein and antibody drugs for use in research, clinical and commercial activities. It produces and purifies these protein and antibody drugs in three process development and manufacturing facilities. In August 2012, GlaxoSmithKline plc acquired HGS.

Receive HGSI News and Ratings via Email

Sign-up to receive the latest news and ratings for HGSI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:HGSI
CUSIPN/A
Phone+1-301-3098504

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

Human Genome Sciences (NASDAQ:HGSI) Frequently Asked Questions

What is Human Genome Sciences' stock symbol?

Human Genome Sciences trades on the NASDAQ under the ticker symbol "HGSI."

Who are some of Human Genome Sciences' key competitors?

How do I buy Human Genome Sciences stock?

Shares of Human Genome Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Human Genome Sciences?

Human Genome Sciences' mailing address is 14200 Shady Grove Rd, ROCKVILLE, MD 20850-7464, United States. The biopharmaceutical company can be reached via phone at +1-301-3098504.


MarketBeat Community Rating for Human Genome Sciences (HGSI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  87 (Vote Outperform)
Underperform Votes:  99 (Vote Underperform)
Total Votes:  186
MarketBeat's community ratings are surveys of what our community members think about Human Genome Sciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Human Genome Sciences (NASDAQ:HGSI) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Human Genome Sciences (NASDAQ:HGSI) Earnings History and Estimates Chart

Earnings by Quarter for Human Genome Sciences (NASDAQ:HGSI)

Human Genome Sciences (NASDAQ HGSI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2012($0.37)($0.46)ViewN/AView Earnings Details
10/25/2011($0.38)($0.45)ViewN/AView Earnings Details
7/21/2011($0.41)($0.42)ViewN/AView Earnings Details
4/28/2011($0.48)($0.69)ViewN/AView Earnings Details
2/24/2011($0.38)($0.46)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Human Genome Sciences (NASDAQ:HGSI) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Human Genome Sciences (NASDAQ:HGSI)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Human Genome Sciences (NASDAQ HGSI)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Human Genome Sciences (NASDAQ HGSI) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Human Genome Sciences (NASDAQ:HGSI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Human Genome Sciences (NASDAQ:HGSI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Human Genome Sciences (NASDAQ HGSI) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.